Cder OC has elected to fill seven of their twelve allotted positions using contractors and five using loan ftes. In addition, OC office of drug security, integrity and response (odsir) seeks one…
Ended Awarded Last action
- Contract number
- 75F40119F19057
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,795,103
Award facts
- Contract value 100% obligated
- $1,795,102.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$645,340 | |
| Supplemental Agreement for work within scope | $224,213 | |
| Exercise an Option | $1,181,766 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,034,463 |
About this award
This contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Brillient Corporation, a management, technology, and business process management firm, to provide administrative support services. The contract is a Blanket Purchase Agreement (BPA) Call under the Professional Services Schedule (PSS) from the General Services Administration (GSA), with a potential value of $1,795,102.96. The contract is being used by the FDA's Center for Drug Evaluation and Research (CDER) Office of Compliance (OC) to bridge staffing gaps and meet commitments under the Generic Drug User Fee Amendments of 2017 (GDUFA II). The contract does not have a set-aside designation and was awarded on May 24, 2019, with a completion date of September 20, 2021. Brillient has provided similar professional and technical services to other federal agencies, including the Department of Homeland Security and National Institutes of Health.
Description
Cder OC has elected to fill seven of their twelve allotted positions using contractors and five using loan ftes. In addition, OC office of drug security, integrity and response (odsir) seeks one contractor to perform administrative support functions. Cder's component offices intend to use these contract slots to bridge the GAP between delays in recruitment efforts and to reduce the need for extensive staff overtime to meet cder OC gdufa II goals and commitments.
Quick answers
Who was awarded contract 75F40119F19057?
75F40119F19057 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on May 24, 2019.
How much is contract 75F40119F19057 worth?
The government has obligated $1,795,103 on 75F40119F19057.
Is contract 75F40119F19057 an order under another contract?
Yes. 75F40119F19057 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75F40119F19057 competed?
The extent of competition for 75F40119F19057 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award